AXGN Q3 2021 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q3 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$31M-6.7% YoY

Gross Profit

$26M83.2% margin

Operating Income

-$7M-21.4% margin

Net Income

-$7M-22.9% margin

EPS (Diluted)

$-0.17

QoQ Revenue Growth

-7.1%

Cash Flow

Operating Cash Flow

-$376,000

Free Cash Flow

-$10M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$210M

Total Liabilities

$95M

Stockholders' Equity

$115M

Cash & Equivalents

$47M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$33M	-6.7%
Gross Profit	$26M	$28M	-6.4%
Operating Income	-$7M	-$1M	-540.1%
Net Income	-$7M	-$1M	-382.8%